Atomo Diagnostics Ltd (AT1) TRADING HALT SUSPENDED

20mins delayed


1 Year Return

Atomo Diagnostics Ltd Chart

Share price
Market Cap $137.62 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

AT1 Statistics

07 August

670 / 2,230

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$137.62 million

Market Cap

Share Issue

404.77 million

All Ords (%)


Short Sold


Current Fundamentals

07 August


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Atomo Diagnostics Limited (AT1) is a medical device company and is establishing an in-house assembly and packing facility in South Africa and has a commercial office in the UK. Its Rapid Diagnostic Test devices are used both by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection.

Atomo Diagnostics Ltd Logo

Corporate Details

Head Office: Leichhardt
Managing Director: John Kelly
GICS Sub-Industry: Health Care Equipment
Date Listed: 16 Apr 2020
Registry: -
Similar Companies: FPH / COH / RMD / ANN / NAN

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.









Broker Consensus data compiled by Market Index.

Directors & Management

About the Data

Name Title Since Bio
Dr Paul Alexander Kasian Non-Executive Director -
Ms Constance (Connie) Bernadette Carnabuci Non-Executive Director Feb 2020
Mr John Perry Keith Non-Executive Chairman, Non-Executive Director Dec 2011
Mr John Michael Kelly Founder, Managing Director Apr 2010
Dr Curt Harold LaBelle Non-Executive Director Oct 2016

Director Transactions

About the Data

AT1 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code AT1 in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Dalraida Holdings Pty Limited 66,160,000 11.79%
Global Health Investment Fund I LLC 63,851,280 11.38%
Walker Group Holdings Pty Ltd 58,285,720 10.39%
National Nominees Limited 32,767,943 5.84%
HSBC Custody Nominees (Australia) Limited 23,632,532 4.21%
Blueflag Holdings Pty Ltd 17,200,000 3.07%
HSBC Custody Nominees (Australia) Limited - A/C 2 13,750,000 2.45%
J P Morgan Nominees Australia Pty Limited 13,537,714 2.41%
Citicorp Nominees Pty Limited 12,606,065 2.25%
Grand Challenges Canada 11,390,824 2.03%
Mainstream Fund Services Pty Ltd (Perennial Private To Public Opportunities Fund) 10,937,500 1.95%
Liverbird Pty Ltd 9,731,653 1.73%
Sokolov Pty Limited (ATF Sokolov Trust) 9,415,077 1.68%
I D E Pty Ltd (ATF Ide Trust) 9,032,248 1.61%
Mark Andrew Smith 7,790,224 1.39%
John Michael Kelly 7,370,248 1.31%
Leo James Lynch and Judith Anne Beswick (The Beswick Lynch Superannuation Fund) 7,321,121 1.30%
BNP Paribas Noms Pty Ltd (DRP) 7,170,746 1.28%
Bosana Nominees Pty Ltd 6,881,496 1.23%
Ian Fredrick Johnson 6,879,560 1.23%
All other shareholders 29.47 %

The Top 20 Shareholders of AT1 hold 70.53% of shares on issue.

AT1 Share Price History

Date Close Change % Change Open High Low Volume Turnover

AT1 Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: The expansion of global sales and continued development of its rapid test device technologies.

Incorporated: --

Level 2, 701-703 Parramatta Rd
Leichhardt NSW 2040

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.